Loading clinical trials...
Loading clinical trials...
Phase 1 Trial of OK-1 (SHetA2) in Patients With Advanced or Recurrent Solid Tumors
Conditions
Interventions
OK-1
Locations
1
United States
Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
Start Date
July 27, 2022
Primary Completion Date
May 1, 2026
Completion Date
June 1, 2027
Last Updated
March 5, 2026
NCT06144671
NCT03594422
NCT05223608
NCT06625775
NCT05888532
NCT06051695
Lead Sponsor
University of Oklahoma
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions